Skip to main content
TipRanks
Go Ultimate75% OFF

Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh (A1LN34) Q2 2026 Earnings Report

BR:A1LN34 Q2 2026 EPS Results

Actual EPS
BRL 0.00
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
BRL 0.00

BR:A1LN34 Q2 2026 Revenue Results

Actual Revenue
BRL 6.52B
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
+48.76%

Earnings Announcement Details

Quarter
Q2 2026
Date
07/30/2026
Time
Before Open
Conference Call
Thursday, July 30, 2026
BR:A1LN34 Upcoming Earnings

Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh's next earnings date is estimated for February 18, 2027, based on past reporting schedules.

Q2 2026 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2026 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2026 Earnings Call Summary

No earnings call summary is available for this earnings event.

BR:A1LN34 Earnings History

BR:A1LN34 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 18, 20272026 (Q4)―-0――
Oct 29, 20262026 (Q3)―0.000300.00% (+0.00)
Jul 30, 20262026 (Q2)―0.000―
Apr 30, 20262026 (Q1)―0.000―
Feb 12, 20262025 (Q4)―0.000―
Oct 30, 20252025 (Q3)―0.000―
Jul 31, 20252025 (Q2)―0.000―
May 01, 20252025 (Q1)―0.000―
Feb 13, 20252024 (Q4)―0.000―
Oct 31, 20242024 (Q3)―0.000―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed